DB99.3ICD-11 MMS 2026-01
Portopulmonary hypertension
Description
This is the coexistence of portal and pulmonary hypertension, and is a serious complication of liver disease, present in 0.25 to 4% of all patients suffering from cirrhosis.
Index terms
- Portopulmonary hypertension
Exclusions from above levels
5D00.0– amyloid degeneration of liverBD71.Y– hepatic vein thrombosisDB94– alcoholic liver disease
Show allHide
DB95– toxic liver diseaseDB98.3– portal vein thrombosisLB20.00– cystic disease of liver (congenital)ME10.00– hepatomegaly NOSME10.1– Unspecified jaundice01– Certain infectious or parasitic diseases02– Neoplasms05– Endocrine, nutritional or metabolic diseases06– Mental, behavioural or neurodevelopmental disorders18– Complications of pregnancy, childbirth and the puerperium22– Injury, poisoning or certain other consequences of external causes
Sibling codes
DB99.0– Chronic liver diseaseDB99.1– Hepatic cystDB99.2– Hepatorenal syndromeDB99.4– Hepatopulmonary syndromeDB99.5– Hepatic encephalopathyDB99.6– Intrahepatic cholestasis, not elsewhere classifiedDB99.7– Hepatic failure without mention whether acute or chronicDB99.8– Chronic hepatic failureDB99.Y– Other specified diseases of liver
Foundation entity
Portopulmonary hypertension – http://id.who.int/icd/entity/1065786072
Allowed postcoordination axes
Part of: DB99: Certain specified diseases of liver › 13: Diseases of the digestive system